May 1, 2026 Log in

News

Shengye Medical Reports May 2026 Revenue of JPY 544 Million (Up +80.2% Year-on-Year)

Citation-Grade Primary-source linked Schema.org verified

Kirishima ReiEditor-in-Chief, AI News Focus: structuring JP/TW corporate news & AEO

Published May 1, 2026 9:00 AM ・ Updated Jun 14, 2026 12:08 AM ・ 2 min read ・ Source: PR Times

Show contents

⚡ Key Points

Shengye Medical announced its revenue for May 2026 reached JPY 544 million, representing an 80.2% increase compared to the same month last year, highlighting strong growth in the biotech and healthcare sector.

Shengye Medical announced its revenue for May 2026 reached JPY 544 million, representing an 80.2% increase compared to the same month last year, highlighting strong growth in the biotech and healthcare sector.

PRIMARY SOURCE PR Times View source Distributor: PR Times
Published: May 1, 2026

Company Code: 4164 Company Name: Shengye Medical Industry: Biotechnology and Healthcare Reporting Month: 2026-05 Monthly Revenue: JPY 543,502 thousand (JPY 544 million) Year-on-Year Change: +80.2%

Keywords: Monthly Revenue, Biotechnology and Healthcare Industry

FACT BOX

Source: PR Times
Category: News
Dates in source: 2026-05

Editorial & Verification Standards

The Washin AI News desk structures and reviews this article under the following standards.

Start only from primary sources (official PR, disclosures, wire services)
Numbers and proper nouns machine-checked against the source (number-completeness check)
Company names and tickers verified via registry (Registry/TWSE/Wikidata)
No speculation; nothing stated that is not in the source

Read the full editorial policy →

Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›

Announced　May 1, 2026 9:00 AM — Distributor PR Times
Collected　Jun 12, 2026 8:00 AM
AI structured & analyzed　Jun 13, 2026 6:38 AM
Desk-reviewed & published　May 1, 2026 9:00 AM

FAQ

What was Shengye Medical's revenue in May 2026?

JPY 544 million, up 80.2% YoY, showing strong biotech sector growth.

What industry is Shengye Medical in?

Biotechnology and healthcare, developing medical products and services.

What does this performance indicate?

Rising market demand and the company's enhanced competitiveness.

What is Shengye Medical's stock code?

Listed on the Tokyo Stock Exchange under code 4164.

Why is future growth expected?

Strong R&D investment and solutions for aging society needs.

Cite this article — HOW TO CITE

Washin AI News Desk“Shengye Medical Reports May 2026 Revenue of JPY 544 Million (Up +80.2% Year-on-Year)”AI News by Washin Village（和心村）, May 1, 2026. https://aeo.washinmura.jp/ai/%E6%89%BF%E6%A5%AD%E9%86%AB/en/news/2026-05-01-%E6%89%BF%E6%A5%AD%E9%86%AB-2026-05-%E6%9C%88%E7%87%9F%E6%94%B6-5-44%E5%84%84-%E5%B9%B4%E5%A2%9E-80-2

AI CRAWLER ACTIVITY

as of Jun 28, 2026

AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)

Site-wide cumulative

ClaudeBot

bot_visits_summary

4102k

last Jun 28, 2026

GPTBot

bot_visits_summary

2490k

last Jun 28, 2026

Google AI

bot_visits_summary

1783k

last Jun 28, 2026

Bingbot

bot_visits_summary

1632k

last Jun 28, 2026

Googlebot

bot_visits_summary

1290k

last Jun 28, 2026

Meta AI

bot_visits_summary

538k

last Jun 28, 2026

※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.

Washin AI News（AI News by Washin Village（和心村））

An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.

Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification

About the publisher IDA llms.txt

Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →

← 承業醫 Back to newsroom (166)

Copied